Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
1,420,952
|
1,292,014
|
1,326,710
|
1,309,934
| Cost of Revenue | 139,111 | 133,197 | 139,637 | 123,527 | |
Gross Profit
|
1,281,841
|
1,158,817
|
1,187,073
|
1,186,407
| |
|
Operating Expenses |
|
Research Development | 329,559 | 355,962 | 338,934 | 301,391 |
|
Selling General and Administrative | 393,138 | 387,241 | 387,533 | 345,373 |
|
Non Recurring | 1,139 | 283 | 636 | 1,803 |
|
Others | 52,282 | 45,961 | 50,867 | 49,347 |
|
|
|
Total Operating Expenses | 776,118 | 789,447 | 777,970 | 697,914 | | |
Operating Income or Loss
|
505,723
|
369,370
|
409,103
|
488,493
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
| 15,144 | (3,973) |
-
|
|
Earnings Before Interest And Taxes | 508,673 | 384,514 | 405,130 | 480,766 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 508,673 | 384,514 | 405,130 | 480,766 |
|
Income Tax Expense | 121,021 | 82,148 | 104,920 | 127,104 |
|
Minority Interest | (295) | 295 | 28 | (1,836) |
|
|
|
Net Income From Continuing Ops | 386,846 | 302,661 | 300,238 | 351,826 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
386,846
|
302,661
|
300,238
|
351,826
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
386,846
|
302,661
|
300,238
|
351,826
|
|